Clinical Trial Update: A Study of RO4989991 in Patients With Allergic Rhinitis [Phase 1]

View source ↗

Summary

Phase 1 trial update of RO4989991 in patients with allergic rhinitis (also listed for asthma) has completed; the snippet does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• RO4989991

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Asthma | Phase 1 | Status: COMPLETED